Purchases and Sales Made in Q3 2023 in Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX) during Q3 2023. The information is specifically focused on institutions that hold shares of Travere Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-701K- 95.52% |
$5.36M - $12.1M
|
32.9K
$668K
|
|
|
Nov 06, 2023
Q3 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-844K- 76.86% |
$6.45M - $14.6M
|
254K
$5.16M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.34M- 23.33% |
$10.2M - $23.1M
|
4.4M
$89.3M
|
|
|
Nov 14, 2023
Q3 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.77M- 99.24% |
$13.5M - $30.6M
|
13.6K
$276K
|
|
|
Nov 14, 2023
Q3 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-6.93M- 99.54% |
$53M - $120M
|
32.2K
$655K
|